Before joining Alexion, Tamar led Federal Executive Branch Strategy and State Government Affairs for Bristol-Myers Squibb. She served as strategic policy advisor and consultant for ADVI, Kimbell & Associates, and Avalere Health. Prior, Tamar was Director of Health Policy & Reimbursement at Molecular Insight Pharmaceuticals (now Progenics) and held health policy and reimbursement leadership strategy roles at GE Healthcare and Bracco Diagnostics. She also held several senior leadership roles for Humana and ValueOptions (now Beacon Health Options).
Tamar holds an MS in Health Sciences from Trident University in Cypress, California and an Executive Leadership certificate from Columbia University. Tamar serves on the board of directors for Avidity Bioscience, MassBio, and Healthy Women. She sits on the Schwartz Center (MassGeneral Hospital) Leadership Council.